Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $24.98 and traded as high as $29.17. Surmodics shares last traded at $28.30, with a volume of 38,556 shares changing hands. Wall Street Analyst Weigh […]
Surmodics, Inc. (NASDAQ:SRDX – Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 180,900 shares, a decline of 30.5% from the May 31st total of 260,200 shares. Currently, 1.3% of the company’s shares are short sold. Based on […]
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA's Center...
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
AlloVir (NASDAQ:ALVR – Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Earnings and Valuation This table compares AlloVir and Vitro Diagnostics’ top-line […]